A cannabinoid drug company has opted to undertake its trials in America due to the complexities of the UK’s licensing regime.
The Association for the Cannabinoid Industry (ACI) and the Centre for Medicinal Cannabis (CMC) are delighted to announce a strategic
THE UK Government signalled its intent to support the country’s burgeoning CBD sector in January this year. In a letter to
THE initial warm welcome to proposals to make UK cannabinoid regulations a matter for the health authorities – not the
A FORMER Minister believes UK doctors will not prescribe cannabis medicine on the NHS until the data exists to prove
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
